相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuraminidase 1 deficiency attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory via AMPK-SIRT3 pathway in diabetic cardiomyopathy mice
Zhen Guo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers
Junxia Wei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function
Yi-le Fu et al.
ACTA PHARMACOLOGICA SINICA (2021)
6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway
Shu-qing Ma et al.
ACTA PHARMACOLOGICA SINICA (2021)
Sorting nexin 3 induces heart failure via promoting retromer-dependent nuclear trafficking of STAT3
Jing Lu et al.
CELL DEATH AND DIFFERENTIATION (2021)
SUMO-specific Isopeptidases Tuning Cardiac SUMOylation in Health and Disease
Paul W. Hotz et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
Xun Shangguan et al.
NATURE COMMUNICATIONS (2021)
PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart
Qinfeng Li et al.
CIRCULATION (2021)
β-Cell Knockout of SENP1 Reduces Responses to Incretins and Worsens Oral Glucose Tolerance in High-Fat Diet-Fed Mice
Haopeng Lin et al.
DIABETES (2021)
Role of the SENP1-SIRT1 pathway in hyperoxia-induced alveolar epithelial cell injury
Wenbin Dong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development
Jianli He et al.
NATURE COMMUNICATIONS (2021)
Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
Somayye Taghvaei et al.
FRONTIERS IN PHARMACOLOGY (2021)
Left ventricular hypertrophy and hypertension
Mehmet Yildiz et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation
Xin Tang et al.
CIRCULATION (2020)
Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3
Shiju Ye et al.
CIRCULATION RESEARCH (2020)
Advanced Heart Failure Epidemiology, Diagnosis, and Therapeutic Approaches
Lauren K. Truby et al.
JACC-HEART FAILURE (2020)
The Gridlock transcriptional repressor impedes vertebrate heart regeneration by restricting expression of lysine methyltransferase
Peilu She et al.
DEVELOPMENT (2020)
The Roles of Noncardiomyocytes in Cardiac Remodeling
Yang Dan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Triad3A attenuates pathological cardiac hypertrophy involving the augmentation of ubiquitination-mediated degradation of TLR4 and TLR9
Xia Lu et al.
BASIC RESEARCH IN CARDIOLOGY (2020)
SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism
Tianshi Wang et al.
MOLECULAR CELL (2019)
TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis
Fang-Yuan Liu et al.
CELL DEATH & DISEASE (2019)
C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice
Zhen-Guo Ma et al.
CARDIOVASCULAR RESEARCH (2019)
Molecular biomarkers in cardiac hypertrophy
Liu Zhu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
An Update on the Multifaceted Roles of STAT3 in the Heart
Zeina Harhous et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
SUMO-specific proteases and isopeptidases of the SENP family at a glance
Kathrin Kunz et al.
JOURNAL OF CELL SCIENCE (2018)
Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura et al.
NATURE REVIEWS CARDIOLOGY (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy
Jae Gyun Oh et al.
CIRCULATION RESEARCH (2018)
Differences in Functional Expression of Connexin43 and NaV1.5 by Pan- and Class-Selective Histone Deacetylase Inhibition in Heart
Xian Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop
Chun-Ping Cui et al.
GUT (2017)
Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway
Di Fan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling
Sheng-an Su et al.
CIRCULATION RESEARCH (2017)
UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts
Manish K. Gupta et al.
CIRCULATION RESEARCH (2016)
The Ubiquitin-Like SUMO System and Heart Function From Development to Disease
Luca Mendler et al.
CIRCULATION RESEARCH (2016)
Physiological and pathological cardiac hypertrophy
Ippei Shimizu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation
Jingjing Wu et al.
ONCOTARGET (2016)
SENP1 regulates PTEN stability to dictate prostate cancer development
Tasneem Bawa-Khalfe et al.
Oncotarget (2016)
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Yow Keat Tham et al.
ARCHIVES OF TOXICOLOGY (2015)
Induction of SENP1 in myocardium contributes to abnormities of mitochondria and cardiomyopathy
Rong Cai et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
The Role of SUMO-1 in Cardiac Oxidative Stress and Hypertrophy
Ahyoung Lee et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway
Jianmin Gu et al.
CARDIOVASCULAR RESEARCH (2014)
Sumoylation: A Regulatory Protein Modification in Health and Disease
Annette Flotho et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Small-Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 Protect Against Angiotensin II-Induced Vascular Dysfunction and Hypertension
Andrew W. Johnson et al.
HYPERTENSION (2013)
Interleukin-10 Treatment Attenuates Pressure Overload-Induced Hypertrophic Remodeling and Improves Heart Function via Signal Transducers and Activators of Transcription 3-Dependent Inhibition of Nuclear Factor-κB
Suresh Kumar Verma et al.
CIRCULATION (2012)
Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat Heart
Saiful Anam Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
SUMO-Specific protease 1 is essential for stabilization of HIF1α during hypoxia
Jinke Cheng et al.
CELL (2007)
Apoptosis-modulating interaction of the neuregulin/erbB pathway with antracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes
S Rohrbach et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
gp130 plays a critical role in pressure overload-induced cardiac hypertrophy
H Uozumi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy
K Kunisada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
